METABOLIC SMALL MOLECULE LIBRARY AND BIOLOGICAL ASSAYS
Metabolic diseases-related small molecule libraries are designed to simplify the very difficult task of identification and development of successful small molecule drugs. Complexity of identified targets, need for more targets, high level toxicity and ADME requirements associated with this area of research are what catalyze ChemDiv’s involvement in Metabolic diseases. Several comprehensive approaches have been employed for the design, synthesis and selection of proposed compound libraries: development of peptidomimetics, analysis of a specific disease’s “targetscape” and selection of appropriate prototypes for virtual screening exercise, neural networks scaffolds sorting, and others. With new small molecule libraries, ChemDiv offers excellent chemical starting points for discovery applications and follow-up development. ChemDiv is constantly updating its chemical libraries and biological assays for metabolic diseases. The following are examples of capabilities:
Please contact our team at [email protected] to discuss your specific needs and application.
METABOLIC IN VIVO
Metabolic in vivo models ChemDiv offers a variety of obesity/diabetes animal models in mice (SHK, ob/ob) and rats (Wistar, Insulin-Resistant Obese Fa/Fa Zucker). Optionally, glucose, insulin, c-peptide, triglycerides and cholesterol blood plasma levels can be measured on the last day of treatment.
Appetite in fasted animals
Acute treatment model
7-day treatment model
7 day and 28 day treatment
7, 14 and 28 day treatment
Take a Look at ChemDiv’s Full List of Small Molecule Libraries